The prevalence of type 2 diabetes mellitus (T2DM) continues to grow worldwide, placing a heavy burden on both patients and healthcare systems. Conventional treatments such as insulin injections and oral hypoglycemic drugs can help regulate blood glucose levels, but they fall short in reversing the course of the disease. In recent years, mesenchymal stem cell…